Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $68.86M.
ENTERPRISE VALUE (EV)
$68.86M
Alps Group Inc
Market Cap
$64.90M
Enterprise Value (EV)
$68.86M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Alps Group Inc (ALPS) | $64.90M | $68.86M |
| Gossamer Bio, Inc. (GOSS)vs › | $65.08M | $63.03M |
| InterCure Ltd. (INCR)vs › | $64.56M | $107.41M |
| Cingulate Inc. (CING)vs › | $63.98M | $41.87M |
| PDS Biotechnology Corporation (PDSB)vs › | $67.11M | $65.87M |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.77M | $20.00M |
| Adicet Bio, Inc. (ACET)vs › | $60.95M | $40.67M |
| MiNK Therapeutics, Inc. (INKT)vs › | $60.78M | $51.97M |
| Champions Oncology, Inc. (CSBR)vs › | $69.05M | $75.66M |
| Fortress Biotech, Inc. (FBIO)vs › | $69.43M | N/A |
Market Cap
$64.90M
Total Debt
$4.57M
Cash
$607473.00
Enterprise Value
$68.86M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
